BioRestorative Therapies Inc (BRTX) support and resistance · rev $401.0K
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
This page maps BioRestorative Therapies Inc (BRTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
BRTX currently screens at market cap $10.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BRTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BRTX quote page for the session range and the stock page for the full model.
Not investment advice.